Osteonecrosis; Femoral head; Bone marrow aspirate concentrate ; Cell therapy ; Mesenchymal stem cells; Hip
Abstract :
[en] Purpose
The fracture stage of non-traumatic osteonecrosis (ON stage 3) of the femoral head (ONFH) has an unfavourable prognosis frequently requiring total hip replacement (THR). The percentage could be lowered after core decompression. In earlier non-fracture ON stages, implantation of autologous bone marrow aspirate concentrate (BMAC) improved the effect of core decompression. The purpose was to evaluate the effect of BMAC in addition to core decompression in stage 3 ONFH.
Methods
A double blind RCT was conducted comparing two groups: core decompression plus saline injection or core decompression plus BMAC implantation. Both patients and assessors were blinded to the treatment assignments. Evaluations were done at baseline, three, six, 12, and 24 months, including pain (VAS), WOMAC, side-effects, radiological evolution including ARCO subclassifications, together with possible THR requirement. The primary endpoint was the need for THR. The second endpoints included the clinical symptoms such as pain and functional ability and the progression of the ON lesions as well as the appearance of osteoarthritis features (ARCO stage 4). Both groups included 23 hips (19 patients).
Results
No differences were found between the groups for THR requirements, clinical tests, and radiological evolution. In both groups, 15/23 hips needed THR. The radiological evolution of the ONFH lesions in term of location, extension, surface collapse, and dome depression was moderate in both groups and was not correlated with the need of THR.
Conclusions
Implantation of BMAC after core decompression did not produce any improvement of the evolution of ONFH stage 3.
Disciplines :
Rheumatology
Author, co-author :
HAUZEUR, Jean-Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Service de rhumatologie
De Maertelaer, Viviane ; Université Libre de Bruxelles - ULB
BAUDOUX, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > Thérapie cellulaire
MALAISE, Michel ; Centre Hospitalier Universitaire de Liège - CHU > Service de rhumatologie
Mont MA, Carbone JJ, Fairbank AC (1996) Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res 324:169–178
Ficat P, Arlet J (1967) Ischémie et nécrose osseuse, exploration fonctionnelle de la circulation intra-osseuse et ses applications. Masson, Paris
Hauzeur JP, Malaise M, de Maertelaer V (2016) A prospective cohort study of the clinical presentation of non-traumatic osteonecrosis of the femoral head: spine and knee symptoms as clinical presentation of hip osteonecrosis. Int Orthop 40:1347–1351
Ficat P, Arlet J, Vidal R, Ricci A, Fournial JC (1971) Therapeutic results of drill biopsy in primary osteonecrosis of the femoral head (100 cases). Rev Rhum Mal Osteoartic 38:269–276
Koo KH, Kim R, Ko GH, Song HR, Jeong ST, Cho SH (1995) Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. J Bone Joint Surg Br 77:870–874
Stulberg BN, Davis AW, Bauer TW, Levine M, Easley K (1991) Osteonecrosis of the femoral head. A prospective randomized treatment protocol. Clin Orthop Relat Res 268:140–151
Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR (2015) Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. J Bone Joint Surg Am 97:1604–1627
Hernigou P, Beaujean F, Lambotte JC (1999) Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br 81:349–355
Gangji V, Hauzeur JP, Schoutens A, Hinsenkamp M, Appelboom T, Egrise D (2003) Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol 30:348–351
Mutijima E, De Maertelaer V, Deprez M, Malaise M, Hauzeur JP (2014) The apoptosis of osteoblasts and osteocytes in femoral head osteonecrosis: its specificity and its distribution. Clin Rheumatol 33:1791–1795
Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 86-A:1153–1160
Gangji V, De Maertelaer V, Hauzeur JP (2011) Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study. Bone 49:1005–1009
Hernigou P, Beaujean F (2002) Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 405:14–23
Gangji V, Hauzeur JP (2005) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique. J Bone Joint Surg Am 87(Suppl 1(Pt 1)):106–112
Hauzeur JP, Pasteels JL, Schoutens A, Hinsenkamp M, Appelboom T, Chochrad I, Perlmutter N (1989) The diagnostic value of magnetic resonance imaging in non-traumatic osteonecrosis of the femoral head. J Bone Joint Surg Am 71:641–649
Mont MA, Marulanda GA, Jones LC, Saleh KJ, Gordon N, Hungerford DS, Steinberg ME (2006) Systematic analysis of classification systems for osteonecrosis of the femoral head. J Bone Joint Surg Am 88(Suppl 3):16–26
Muschler GF, Boehm C, Easley K (1997) Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am 79:1699–1709
Hauzeur JP, Orloff S, Taverne-Verbanck J, Pasteels JL (1986) Diagnosis of aseptic osteonecrosis of the femoral head by percutaneous transtrochanterian needle biopsy. Clin Rheumatol 5:346–358
Frank AJ, Moll JM, Hort JF (1982) A comparison of three ways of measuring pain. Rheumatol Rehabil 21:211–217
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840
Gardeniers JW (1992) A new international classification of osteonecrosis of the ARCO Committee on terminology and classification. J Jpn Orthop Assoc 66:18–20
Mont MA, Zywiel MG, Marker DR, McGrath MS, Delanois RE (2010) The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am 92:2165–2170
Wang BL, Sun W, Shi ZC, Zhang NF, Yue DB, Guo WS, Xu SQ, Lou JN, Li ZR (2010) Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg 130:859–865
Yoshioka T, Mishima H, Akaogi H, Sakai S, Li M, Ochiai N (2011) Concentrated autologous bone marrow aspirate transplantation treatment for corticosteroid-induced osteonecrosis of the femoral head in systemic lupus erythematosus. Int Orthop 35:823–829
Gangji V, Rooze M, De Maertelaer V, Hauzeur JP (2009) Inefficacy of the cementation of femoral head collapse in glucocorticoid-induced osteonecrosis. Int Orthop 33:639–642